Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RTTR

Ritter Pharmaceuticals (RTTR) Stock Price, News & Analysis

Ritter Pharmaceuticals logo

About Ritter Pharmaceuticals Stock (NASDAQ:RTTR)

Advanced Chart

Key Stats

Today's Range
$3.32
$3.65
50-Day Range
$0.45
$4.09
52-Week Range
$0.15
$1.27
Volume
8,518 shs
Average Volume
14.23 million shs
Market Capitalization
$158.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RTTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ritter Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RTTR Stock News Headlines

Dr. John D. Ritter
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Kristen Ritter
Dr. Harold K. Ritter
Denver Business Journal welcomes new tech reporter
See More Headlines

RTTR Stock Analysis - Frequently Asked Questions

Ritter Pharmaceuticals Inc (NASDAQ:RTTR) posted its quarterly earnings data on Friday, May, 1st. The biotechnology company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.01.

Ritter Pharmaceuticals shares reverse split before market open on Friday, March 23rd 2018.The 1-10 reverse split was announced on Thursday, March 22nd 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 22nd 2018. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Ritter Pharmaceuticals (RTTR) raised $20 million in an IPO on Wednesday, June 24th 2015. The company issued 4,000,000 shares at a price of $5.00 per share. Aegis Capital Corp and Chardan Capital Markets served as the underwriters for the IPO and Barrington Research was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ritter Pharmaceuticals investors own include Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), APA (APA), Charles Schwab (SCHW), Genocea Biosciences (GNCA) and Hudson Technologies (HDSN).

Company Calendar

Last Earnings
5/01/2020
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RTTR
CIK
1460702
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.13 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.10 per share
Price / Book
34.30

Miscellaneous

Free Float
N/A
Market Cap
$158.30 million
Optionable
Not Optionable
Beta
-0.43
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:RTTR) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners